BRAF and melanoma: In our study, 32.9 % of the patients (26/79) were concluded to have a BRAF-mutated melanoma (22.8 % (18/79) BRAFV600E, 6.3 % (5/79) BRAFV600Kand 3.7 % (3/79) BRAFV600R).